In Alzheimer’s disease, TNF-α has been linked to amyloid-beta (Aβ) plaque accumulation and synaptic dysfunction [118], whereas in Parkinson’s disease, TNF-α-mediated microglial activation leads to dopaminergic neuron degeneration [119]. Here, TNF is linked to Parkinson disease.